A new multi-modal optical coherence tomography and autofluorescence imaging technology

About

There is an unmet need to reliably detect high-risk plaques before they are life threatening. We have developed a new multi-modal OCT (structural) and autofluorescence imaging (biology) technology. This novel design resolves the inherent conflicting optical properties needed by each imaging modality in a single-fibre multimodality system, while ensuring that the system is highly miniaturised. The innovation involves two-photon 3D printing to create a complex micro-optical lens for fluorescence and OCT.

Applications

The major application is for detection of high-risk plaques (cardiovascular diseases). However other uses include imaging for lung cancer, gene therapy, gastrointestinal tract and the bile duct for cancers such as cholangiocarcinoma.

Register for free for full unlimited access to all innovation profiles on LEO

  • Discover articles from some of the world’s brightest minds, or share your thoughts and add one yourself
  • Connect with like-minded individuals and forge valuable relationships and collaboration partners
  • Innovate together, promote your expertise, or showcase your innovations